RNAC

6.1404.24%
EE

Emily English

Chief Operating Officer

Dr. Emily English, Ph.D. serves as Chief Operations Officer of Cartesian Therapeutics, Inc. since January 2025 and served as its Senior Vice President, Head of Manufacturing Operations from April 2024 to January 2025 and as its Vice President, Quality from November 2023 to April 2024. Dr. English served as Vice President, Quality at Old Cartesian from December 2022 to November 2023 and had previously served as Old Cartesian’s Senior Director, Quality, from December 2021 to December 2022 and its Director, Quality from April 2021 to December 2021. Dr. English served as Venture Partner at Baltimore Venture Partners, a private investment firm, from August 2020 to April 2021. She also served as Chief Executive Officer of Gemstone Biotherapeutics, a private biotechnology company, from June 2018 to June 2020 and as Chief Operating Officer at Gemstone from June 2017 to May 2018. Dr. English also served on the Board of Directors of the BioTechnical Institute of Maryland, Inc. from December 2018 to June 2021 and served on the advisory board of the University of Maryland’s Department of Bioengineering from July 2019 to June 2021. Dr. English holds a bachelor’s of science degree in Chemistry from the University of Maryland and a Ph.D. in Chemistry from the University of Wisconsin-Madison.

公司職務